RADCOM Ltd. (RDCM)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	210	196	121	158	184	153
Market Cap Growth	50.59%	61.72%	-23.41%	-13.88%	20.52%	30.45%
Enterprise Value	115	107	44	90	119	93
Last Close Price	13.65	12.36	8.06	10.94	13.05	10.95
PE Ratio	25.80	28.17	32.69	-	-	-
Forward PE	15.34	15.07	13.43	60.78	-	-
PS Ratio	3.40	3.22	2.35	3.44	4.57	4.07
PB Ratio	2.19	2.05	1.47	2.18	2.62	2.12
P/TBV Ratio	2.10	2.11	1.53	2.18	2.62	2.12
P/FCF Ratio	-	17.91	27.13	27.00	117.58	-
P/OCF Ratio	-	17.24	25.79	26.33	91.91	-
EV/Sales Ratio	1.74	1.75	0.86	1.96	2.96	2.48
EV/EBITDA Ratio	17.91	28.40	2775.35	-	-	-
EV/EBIT Ratio	20.13	34.64	-	-	-	-
EV/FCF Ratio	-	9.76	9.93	15.39	76.17	-
Debt / Equity Ratio	0.03	0.04	0.02	0.03	0.03	0.04
Debt / EBITDA Ratio	0.47	0.69	1.41	-	-	-
Debt / FCF Ratio	-	0.31	0.36	0.42	1.24	-
Asset Turnover	0.52	0.51	0.50	0.48	0.44	0.40
Inventory Turnover	17.02	16.06	25.62	14.28	15.53	11.35
Quick Ratio	4.93	4.10	4.78	3.74	4.98	5.48
Current Ratio	4.98	4.20	4.84	3.84	5.14	5.60
Return on Equity (ROE)	9.74%	7.82%	4.78%	-3.16%	-7.40%	-5.47%
Return on Assets (ROA)	2.82%	1.62%	-0.36%	-2.67%	-3.71%	-3.01%
Return on Capital (ROIC)	3.62%	2.11%	-0.47%	-3.49%	-4.67%	-3.69%
Return on Capital Employed (ROCE)	5.10%	3.00%	-	-	-	-
Earnings Yield	4.40%	3.55%	3.06%	-1.42%	-2.86%	-2.61%
FCF Yield	-	5.58%	3.69%	3.70%	0.85%	-0.31%
Buyback Yield / Dilution	-7.02%	-5.60%	-5.32%	-2.84%	-1.41%	-1.07%

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q